Menu

Venter’s New Digs

Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.

Oct 9, 2013
Bob Grant

WIKIMEDIA, VIA PLOS ONEGenomicist and entrepreneur Craig Venter is erecting a $37-million, 45,000-square-foot building nestled in the University of California, San Diego, campus and near the Salk Institute in La Jolla, California. The building, which is expected to open on November 9, will be a satellite campus for his Rockville, MD-based J. Craig Venter Institute and will house 125 scientists and staff, according to the San Diego Union Tribune. “I wanted a special property that went with the special nature of the institute and, if possible, to be overlooking the ocean,” Venter told the Union Tribune.

The latest addition to the vibrant life science hub in San Diego has Venter’s neighbors pretty excited. “Craig is an extremely creative guy,” Michael Marletta, CEO of The Scripps Research Institute, told the Union Tribune. “He pushes the envelope beyond what people thought, he has provocative ideas, [and] he acts on those ideas. So to have him here is a big plus for us.”

Larry Goldstein, a UC San Diego stem cell researcher who has collaborated with Venter, shared Marletta’s enthusiasm. “When you bring a guy of his energy and creativity permanently into our community, he’s going to create value,” he said. “He’s going to create new areas that we’re going to investigate scientifically.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.